Once-weekly injectable Wegovy plus lifestyle modification conferred a greater reduction in BMI than placebo among children aged 6 to 11 years with obesity, according to topline results from the STEP Young trial.
September 08, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection…
More than half of adults who used once-weekly semaglutide for obesity treatment discontinued the drug after less than 1 year,…
Doctors are looking for better options given the growing awareness of the serious health risks tied to childhood obesity. |…
The pills could be offered as an alternative to weight loss injections
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much…
The stronger Wegovy dose could see more than 20 per cent weight loss in patients with obesity
